Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 06-2016 | 06-2015 | 12-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,847 | -8,268 | -18,064 | N/A | -9,225 |
| Depreciation Amortization | 8 | 93 | 177 | 100 | 350 |
| Income taxes - deferred | N/A | -680 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,250 | -142 | -669 | N/A | -145 |
| Other Working Capital | 917 | -212 | -1,014 | 890 | 1,029 |
| Other Operating Activity | -1,172 | 5,532 | 12,225 | 11,460 | 3,123 |
| Operating Cash Flow | $-8,844 | $-3,676 | $-7,345 | $12,450 | $-4,868 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | N/A | -123 | -110 | -3 |
| Net Acquisitions | N/A | N/A | N/A | 0 | 1,275 |
| Purchase Sale Intangibles | N/A | 0 | -137 | N/A | -625 |
| Other Investing Activity | 0 | 0 | -137 | -420 | -625 |
| Investing Cash Flow | $-36 | $N/A | $-260 | $-530 | $647 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,152 | 4,828 | N/A | 10,917 |
| Other Financing Activity | 9,736 | 0 | 0 | 0 | -2,187 |
| Financing Cash Flow | $9,736 | $1,152 | $4,828 | $N/A | $8,730 |
| Beginning Cash Position | 1,394 | 3,335 | 6,111 | N/A | 1,602 |
| End Cash Position | 2,250 | 811 | 3,335 | N/A | 6,111 |
| Net Cash Flow | $856 | $-2,524 | $-2,777 | $11,920 | $4,509 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,844 | -3,676 | -7,345 | 12,450 | -4,868 |
| Capital Expenditure | -36 | 0 | -123 | N/A | -3 |
| Free Cash Flow | -8,880 | -3,676 | -7,467 | 12,450 | -4,871 |